Navigation Links
Inordinately Long Waiting Times at A&E Infirmary

Edinburgh Royal Infirmary's accident and emergency unit is said to make patients wait longer than anywhere else in Scotland to be seen by a doctor.//

This news has only added salt to the wound of hospital chiefs who face mounting criticism over cleaning procedures at the ERI following its branding as one of the dirtiest hospitals in the country earlier this week.

Recent figures have shown that more than a third of patients attending A&E spend over four hours waiting to be seen at the hospital.

However health bosses have shifted blame to the Marmion Pub shootings in Gracemount for influencing the recent figures as it happened while the waiting time survey was taking place. According to then the massive resources needed to cope with the aftermath of the shooting at Scotland's busiest A&E had affected waiting times for other patients.

The Scottish Executive has demanded improvement in waiting times by the end of next year to no longer than four hours between arriving at the A&E unit and admission to hospital, discharge or transfer. The new NHS statistics show that during the seven-day April survey, just under 2000 patients were seen by the doctors at ERI. Among these 1012 minor cases and 946 were serious medical problems.

80 per cent of the minor health complaints were treated within the target time although over half of the patients with a major problem were made to wait much longer. The most frequent reason given for the delay was the lack of availability of beds.

NHS Lothian's clinical director for medicine, Dr Casey Stewart, said: "We are very disappointed not to have met the four-hour standard for this period of what is a very busy time for us. We have worked tremendously hard on innovative ways of reducing the time it takes for us to see and treat patients and we feel the unexpectedly high levels of activity during the days of the census has masked the real improvements we are making in our service.

'"/>




Page: 1 2

Related medicine news :

1. Mobile Operating Theater to Cut Waiting Times
2. NHS To Achieve Waiting Figure Target By 2008
3. Gynecologist Solving SuDoKu, While Waiting For Next Patient
4. New Study To Determine "Watchful Waiting" Period For Prostate Cancer
5. 800 People On US Waiting List for AIDS Drugs
6. Funds Pumped In To Reduce Waiting List of Priority Patients
7. UK Patients Seek Fertility Treatment Abroad Due To The Long Waiting List
8. Waiting Period Of Over 10yrs For Women Needing Breast Reduction Surgery
9. Long Patient Waiting Times Force NHS Patients To Seek Treatment Abroad
10. Health Minister Praises Efforts By NHS In Reducing Patient Waiting Time
11. Waiting list in British healthcare causing them to shell out a fortune!
Post Your Comments:
(Date:7/25/2008)... Though the number of jobs created...al companies reported a different kind of slowdown...ous months. , Seattle, WA...s created in the medical field slowed in June over... kind of slowdown that will be music to the ears o...
(Date:7/25/2008)...cKesson Corporation Executive, Robert J. Reilly, J.../ -- Aethon Inc.,( http://www.aethon.com ), the le...pply chain logistics, today announced that Robert ...esident -- Chief Financial Officer., Reilly, who ...r for,McKesson Corporation,s Specialty Pharmacy Di...
(Date:7/25/2008)...ds fluid back-up in esophagus can cause immune sys...ay News) -- The first evidence linking gastroesoph...scovered by Duke University Medical Center researc...ns was first noted in the 1970s, and since then st...rcent of asthma patients also experience GERD symp...
(Date:7/25/2008)... The Drug Information Association ...ill host the Critical Path Initiative (CPI) on the...16; Bethesda, MD) and the Critical Path Transporte... Horsham, PA (PRWEB) July 25...mation Association (DIA)] and the Food and Drug Ad...
Breaking Medicine News(10 mins):Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3Health News:Aethon, Inc. Names New Chief Financial Officer 2Health News:People With GERD More Likely to Develop Asthma 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3
...gy segment, pharma major Dr Reddys Laboratories Lt...ailable// in extended release tablets of 10 mg dos...he brand name 'Alfoo' is indicated for treatment o...ing men known as Benign Prostatic Hyperplasia (BPH...
...overed a method to cease the blood supply to cance... cancer//. This, if proved conclusively, will infu...ng to the scientists, a protein, discovered while ...pable of stopping the blood supply to tumors, thus...
...tropolis Health Services (India) plans to make Dub...dle East//. In a joint venture with United Arab Em... Metropolis is set to begin formal operations of i...i in August, though the soft launch took place las...
...ter when investigating for an alternative menopaus...ated hot flashes as good as estrogen. Gabapentin,...the flow of calcium in and out of the cells, which...ature. flow risks like was researchers, who have ...
Other Medicine News:Health News:Metropolis Health Plans Middle East hub in Dubai 2Health News:Gabapentin Reduced Menopausal Symptoms as Estrogen – Study Find 2
(Date:7/24/2008)...EW, Calif., July 24 /- Alex...d today that it has initiated,its second Phase 3 c...AZ-004 is an inhalation product candidate being de...tients with schizophrenia or bipolar disorder.,Ale...pid pharmacokinetic,(PK) properties resulting from...
(Date:7/24/2008)...uly 24 /- MacroChem Corpora...sults of a Phase 2 clinical trial,involving 37 pat...open-label efficacy and safety study of EcoNail, a...nychomycosis (nail fungus). The composite,primary ... defined as,negative mycology (negative fungal cul...
(Date:7/23/2008)... July 23 /PRNewswire-USNewswire/ -- The following ...Chairman Conyers, Ranking Member Smith, and Member...to testify today., Since I appeared before this C... better acquainted with the talented and dedicated...the work they do, and I have come to,appreciate th...
(Date:7/23/2008)...used on IND-Enabling Work with Protein Therapeutic...omplement System, CAMBRIDGE, Mass., July 23 /PRNe...ed it has initiated a corporate growth plan with t...executive officer and the,establishment of its hea...s,Woodruff Emlen, M.D., a co-founder of the compan...
Breaking Medicine Technology:Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Brown named Center of Excellence in Geriatric Medicine and Training 8968 1Brown named Center of Excellence in Geriatric Medicine and Training 8968 2Brown named Center of Excellence in Geriatric Medicine and Training 8968 3American College of Physicians receives grant to study cost of patient centered medical home 8965 1American College of Physicians receives grant to study cost of patient centered medical home 8965 2New discovery could reduce the health risk of high fat foods 1754 1Resilience concepts poised to aid management of coastal marine ecosystems 1751 1Resilience concepts poised to aid management of coastal marine ecosystems 1751 2
...Newswire-FirstCall/ -- Rigel Pharmaceuticals, Inc....s currently in ongoing,Phase 2 clinical trials in ...arthritis (RA) and lymphoma patients. R788 is a no...ivation of mast cells,macrophages and B-cells tha...sue damage. , Rigel commenced an exploratory Phase...
...ce in Barcelona,Spain, VANCOUVER and SAN DIEGO, C... Inc. , a clinical-stage developer,of drugs for in...ts,confirming the previously announced clinical re...inical benefit, safety and,tolerability in a Phase...or, celgosivir (MX-3253), in combination with pegy...
Other Medicine Technology:Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP,Rheumatoid Arthritis and Lymphoma 2Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP,Rheumatoid Arthritis and Lymphoma 3Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP,Rheumatoid Arthritis and Lymphoma 4New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 2New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 3New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 4New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 5New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 6New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 7New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 8